Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jules Leonard Dienstag, M.D.

Co-Author

This page shows the publications co-authored by Jules Dienstag and Raymond Chung.
Connection Strength

1.050
  1. The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence. Hepatology. 2021 Mar 30.
    View in: PubMed
    Score: 0.249
  2. The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci. 2011 Feb; 56(2):564-8.
    View in: PubMed
    Score: 0.122
  3. Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol. 2009 Oct; 30(10):1000-5.
    View in: PubMed
    Score: 0.112
  4. Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):266-72.
    View in: PubMed
    Score: 0.076
  5. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection. Am J Gastroenterol. 2002 Feb; 97(2):478-83.
    View in: PubMed
    Score: 0.066
  6. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proc Natl Acad Sci U S A. 2020 05 26; 117(21):11667-11673.
    View in: PubMed
    Score: 0.058
  7. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol. 1999 Aug; 58(4):353-8.
    View in: PubMed
    Score: 0.055
  8. Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes. Dig Dis Sci. 2020 01; 65(1):312-321.
    View in: PubMed
    Score: 0.055
  9. Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study. Liver Transpl. 2019 06; 25(6):859-869.
    View in: PubMed
    Score: 0.054
  10. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019 11; 17(12):2592-2599.
    View in: PubMed
    Score: 0.054
  11. Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2018 01 06; 13(1):16-25.
    View in: PubMed
    Score: 0.049
  12. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One. 2012; 7(2):e27144.
    View in: PubMed
    Score: 0.033
  13. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology. 2011 Jul; 141(1):141-9.
    View in: PubMed
    Score: 0.031
  14. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005 Sep; 43(3):434-41.
    View in: PubMed
    Score: 0.021
  15. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation. 1998 Nov 15; 66(9):1254-8.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.